ASX
NeuroScientific Biopharmaceuticals Ltd
NSB:ASX•Healthcare
Sensitive ASX Announcement
NSB to investigate treatment for post-COVID Fibrosis
Published: 20/11/20, 10:56am (AEST)•3 pages